Clinical implication:** PSS can help **early identification of high-risk pediatric patients** and guide timely interventions in the PICU.
Friday, 20 February 2026
P PHOENIX SEPSIS SCORE
* **Study Title:** Phoenix Sepsis Score: Predictive Accuracy for Clinical Deterioration in Pediatric Critical Care
* **Authors:** Hadzhieva-Hristova A, Krumova D, Halilova M, Tsotchev K, Karamfilova T, Deyanova Y, Zlateva T, Bazdarska Y, Stoeva T, Iotova V
* **Institutions:**
* Medical University of Varna
* St. Marina University Hospital
---
### **Background**
* Early detection of **pediatric sepsis complications** in intensive care is difficult.
* Existing scoring systems:
* **PRISM III**
* **PELOD-2**
* **pSOFA**
* **Phoenix Sepsis Score (PSS)**
* Objective: Compare predictive accuracy of PSS with other scores for identifying clinical deterioration in PICU patients.
---
### **Methods**
* **Study design:** Prospective data collection
* **Population:** 53 children (June 2022 – January 2024)
* Septic: 42
* Non-infectious SIRS: 11
* Outcomes: With complications (23) / Without complications (30)
* **Assessment:**
* Scoring systems evaluated for **discrimination** and **calibration**
* Recalibration performed for PSS
* Predictive power assessed via **Area Under Precision-Recall Curve (AUPRC)**
---
### **Results**
* **Common complications:**
* Respiratory: 18.8%
* Neurological: 9.4%
* **Clinical deterioration:** 43.4% (including 1 fatality)
* **PICU stay:** Longer in patients with complications (14 ± 10 days)
* **Score comparisons:**
* All scores higher in patients with complications
* **Only PSS significant:** p = 0.0023
* **Overall predictive accuracy:**
* PSS: 76.2% (highest)
* PRISM III: 62.3%
* PELOD-2: 58.5%
* **pSOFA:** High accuracy (88%) in identifying patients **without complications**
* **Precision for complications (AUPRC):**
* PSS & PRISM III: 0.62
* **Risk factors:**
* Chronic disease: Exp(B) = 1.718 → higher risk
* Mechanical ventilation: Exp(B) = 0.509 → lower risk
---
### **Conclusions**
* **Phoenix Sepsis Score (PSS)**:
* Superior predictive accuracy (76.2%)
* Best discriminative capacity for detecting clinical deterioration
* Outperformed PRISM III and PELOD-2 in this cohort
* Adaptable for **larger-scale validation** in pediatric critical care populations
* **
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment